MONTREAL, CANADA--(Marketwired - Sept. 9, 2014) - Affinor Growers (CSE:AFI)(OTCQB:RSSFF)(FRANKFURT:1AF) ("Affinor" or the "Corporation) has signed an agreement with Herbal Analytics, a Washington State testing laboratory, to provide quality control for cannabis products . Herbal Analytics has the staff, instrumentation, and procedures necessary to comply with the scope of tests that Washington State requires for SI502 quality control of Cannabis and associated derivatives.

Herbal Analytics has extensive herbal product industry experience with an edge using the most efficient and innovative analytical platforms for accurate and rapid results. Herbal Analytics chemical tests have been legitimized and proven, based on Bio Analytical Method Validation for accuracy and precision.

Herbal Analytics brings a wide range of services to Affinor Growers, providing them with critical data on which to base informed business decisions. The laboratory's background in Botanical Medicine puts them first in the industry for guided intelligence in product development for specific plant chemotypes and standardization for efficacy.

Under the terms, Affinor Growers paid $150,000 cash, $150,000 in a repayable loan over a maximum of 4 years and issued 949,612 of Affinor common shares at $0.516 per share for 49%. The proceeds will be used to build the laboratories to meet the demand and handling the volume necessary of SI-502 and medical clients in Washington State, including, but not limited to, the equipment, employee salaries, marketing, sales and regular business needs.

Sebastien Plouffe, President and CEO, comments: "This relationship is another demonstration of Affinor's commitment to become the ultimate grower and supplier of high quality cannabis products in Washington State and the expanding legalized states and countries. This is a profitable business and Affinor is thrilled to have a 49% participation in the profit of Herbal Analytics".

About Affinor Growers Inc.

Affinor Growers is a diversified publicly traded company on the Canadian Securities Exchange under the symbol ("AFI"). Affinor is focused on growing high quality crops such as romaine lettuce, spinach, strawberries and high quality medical Marijuana. Affinor is committed to becoming a pre-eminent grower, using exclusive vertical farming techniques.

On Behalf of the Board of Directors
"Sebastien Plouffe"
President & CEO

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.


This News Release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on This News Release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Contact Information:

Contact Information
Sebastien Plouffe
President & CEO
(514) 947-2272

Contact Information, spokesperson
Affinor Growers
Nick Brusatore, Executive Chairman
(604) 356-0411